The Michigan Economic Development Corp., the Greater Wayne Economic Development Corp. and a private foundation are pooling $3.5 million to buy the former Esperion Therapeutics headquarters building in Plymouth Township from Pfizer Inc., the groups announced Wednesday. The building will be purchased in Ann Arbor Spark's name, and Spark will run it until a nonprofit group is set up to... Full story »
Only 200 Pfizer employees remain working in Ann Arbor as the company stays on track to close its research and development facilities during the fourth quarter, a company spokesman said. Full story »
Call it the perfect birthday gift for Roger Newton. On Thursday, the founder of Esperion Therapeutics - a Plymouth Township based biopharmaceutical company that Pfizer bought for $1.3 billion four years ago - announced the company is being revived to continue studying cholesterol drugs. The announcement, which fell on Newton's birthday, came nearly a year after Esperion closed its doors... Full story »
Esperion Therapeutics, the biopharmaceutical company that was sold to Pfizer Inc. for $1.3 billion four years ago, is being revived to continue its study of cholesterol drugs. In a statement released early today, Pfizer said it sold its Esperion division, along with selected programs and related assets, to a group of investors. Pfizer is maintaining a financial stake in the... Full story »
By Stefanie Murray | The Bill & Melinda Gates Foundation appears to be eyeing the soon-to-be-shuttered Pfizer research labs in Ann Arbor. One of the foundation's top executives made mention of the site during a live presentation and Webcast earlier this week with Pfizer Inc. workers in New York City. • Read the storyFull story »
By Stefanie Murray | The $10 billion publicly traded national real estate company that recently transformed a former Pfizer Inc. research site in Illinois into a multicompany biotechnology hub confirmed Thursday that it toured the soon-to-be-shuttered Pfizer property in Ann Arbor last year. • Read the storyFull story »
By Stefanie Murray | This Tuesday marks the one-year anniversary of Pfizer's stunning announcement that it would close its sprawling research and development facilities in Ann Arbor by the end of 2008. A year ago, Pfizer had 2,100 scientists and researchers working at its Ann Arbor site. Today, those numbers have dwindled to less than 400. • Read the storyFull story »
Stories in this series: • One year later: Pfizer labs emptying out • Canter talks about Pfizer transition • Researcher shares view from inside • Pfizer's loss is other companies' gain • Effects of Pfizer closure widespread • Ongoing coverage of Pfizer closing Dr. David Canter, who has been head of Pfizer's Ann Arbor site for eight years, talks... Full story »
"It's been a year of adjustments; I had my first child, lost a job and got a new one." - former Pfizer chemist Nancy Barta. Stories in this series: • One year later: Pfizer labs emptying out • Canter talks about Pfizer transition • Researcher shares view from inside • Pfizer's loss is other companies' gain • Effects of... Full story »
Stories in this series: • One year later: Pfizer labs emptying out • Canter talks about Pfizer transition • Researcher shares view from inside • Pfizer's loss is other companies' gain • Effects of Pfizer closure widespread • Ongoing coverage of Pfizer closing The closing of Pfizer means much more to the community than the loss of more than... Full story »
Stories in this series: • One year later: Pfizer labs emptying out • Canter talks about Pfizer transition • Researcher shares view from inside • Pfizer's loss is other companies' gain • Effects of Pfizer closure widespread • Ongoing coverage of Pfizer closing Editor's note: Mary Beth Dunklee, 30, is a resident of Dexter. She is a former Pfizer... Full story »
University of Michigan President Mary Sue Coleman said U-M will set aside $1 million a year for three years to attract and retain Pfizer scientists as university employees. "We want to make sure it doesn't seem best for people to go away," Coleman told about 300 members of the Ann Arbor business community Thursday at a "Michigan Leaders Speak" forum... Full story »
University of Michigan President Mary Sue Coleman said U-M will set aside $1 million a year for three years to attract and retain Pfizer scientists as university employees. "We want to make sure it doesn't seem best for people to go away," Coleman told about 300 members of the Ann Arbor business community this morning at a "Michigan Leaders Speak"... Full story »
comments